ArticlePloS one2013

Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myeloma.

Martin Bøgsted et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.